Impact of atherogenic lipoproteins and inflammatory markers on silent atherosclerosis
Atherogenic lipoproteins are causal drivers of atherosclerotic cardiovascular disease (ASCVD). Emerging data has implicated inflammation as a key contributor to ASCVD. However, in adults without established ASCVD, it remains uncertain whether atherogenic lipid-plaque associations persists after accounting for mea...